MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome

Jennifer A. Byrne*, Sanaz Maleki, Jayne R. Hardy, Brian S. Gloss, Rajmohan Murali, James P. Scurry, Susan Fanayan, Catherine Emmanuel, Neville F. Hacker, Robert L. Sutherland, Anna deFazio, Philippa M. O'Brien

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)
5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome'. Together they form a unique fingerprint.

Medicine & Life Sciences